Back

The future: gene editing

30 August 2026 (18:06 - 18:18)
Organised by: Logo
Congress Presentation Part of: Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing Risk Factors and Prevention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Andreas Michael Zeiher

Institute of Cardiovascular Regeneration, Frankfurt (Germany)

4 More presentations in this session

Presentation thumbnail
The discovery of PCSK9
Professor C. Boileau (Paris, FR)
Slides Video
Presentation thumbnail
The present: antibodies siRNAs
Professor K. Ray (London, GB)
Slides Video
Presentation thumbnail
Oral PCSK9 inhibitors
Doctor C. Ballantyne (Houston, US)
Slides Video
Presentation thumbnail
Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing - discussion
Video

Access the full session

Session thumbnail
Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 18:06 CET
You may be interested in
thumbnail
Congress Presentation
Can gene editing address unmet need in dyslipidaemia?
30 August 2025
thumbnail
Congress Presentation
CRISPR-Cas base editing to eliminate CaMKIIδ autophosphorylation as a therapy against arrhythmias
30 August 2026
thumbnail
Congress Presentation
Editing the future: gene therapies transforming cardiomyopathy care
29 August 2026
thumbnail
Congress Presentation
Action mechanism of siRNAs
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources